Literature DB >> 1035129

Presence of cellular rentinol and retinoic acid binding proteins in experimental rumors.

D E Ong, F Chytil.   

Abstract

Cellular retinol and retinoic acid binding proteins were detected in mouse skin papillomas, human adenocarcinoma HAD-1, Dunning Leukemia, Walker 256 carcinosarcoma and mammary adenocarcinoma MAC-1. A chondrosarcoma and Sarcoma 180 apparently contain only the cellular retinoic acid binding protein. Neither protein could be detected in Ehrlich carcinoma and L1210 leukemia. The presence of these proteins might be necessary for sensitivity to retinoid therapy.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1035129     DOI： 10.1016/s0304-3835(76)80006-7

Source DB:  PubMed          Journal:  Cancer Lett        ISSN： 0304-3835            Impact factor:   8.679


  6 in total

1.  Localization of cellular retinol-binding protein in several rat tissues.

Authors:  S B Porter; L D Fraker; F Chytil; D E Ong
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

Review 2.  Inhibition of carcinogenesis by retinoids.

Authors:  P Nettesheim
Journal:  Can Med Assoc J       Date:  1980-04-05       Impact factor: 8.262

3.  Cellular retinoic acid-binding protein and its relationship to the biological activity of four synthetic retinoids in hamster tracheal organ culture.

Authors:  R G Mehta; L J Schiff; S J Moore; A M Buckley; M I Dawson
Journal:  In Vitro Cell Dev Biol       Date:  1986-03

4.  Relationship between cellular retinoic acid-binding protein and histology of human lung tumors.

Authors:  F V Kohl
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

Review 5.  Retinoids and cancer.

Authors:  W Bollag
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

6.  Binding of retinoids to human breast cancer cell lines and their effects on cell growth.

Authors:  A Lacroix; M E Lippman
Journal:  J Clin Invest       Date:  1980-03       Impact factor: 14.808
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.